Skip to main content
22 articles related to "Dlts"

Articles

Clinical Trial

Published on 23 Oct 2023

A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor activity of QL1604, a humanized anti–PD-1 mAb, in patients with advanced or metastatic solid tumors

in Cancer Immunity and Immunotherapy

  • Zhiyu Huang
  • Yanjun Xu
  • Wei Hong
  • Lei Gong
  • Kaiyan Chen
  • Jing Qin
  • Fajun Xie
  • Feng Wang
  • Xin Tian
  • Xiangrui Meng
Frontiers in Immunology
doi 10.3389/fimmu.2023.1258573
  • 9,611 views
  • 3 citations